Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin morning vs bedtime in cardiovascular disease
NCT05932472Phase 4Recruiting
- Start
- Jan 2024
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in atherosclerotic cardiovascular disease (ASCVD). Started Jan 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT05932472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05932472.